Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
C1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. Parallel determination of...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00794/full |
| _version_ | 1818155190497312768 |
|---|---|
| author | Erika Kajdácsi Zsófia Jandrasics Nóra Veszeli Veronika Makó Anna Koncz Dominik Gulyás Kinga Viktória Köhalmi Kinga Viktória Köhalmi György Temesszentandrási László Cervenak Péter Gál József Dobó Steven de Maat Coen Maas Henriette Farkas Henriette Farkas Lilian Varga Lilian Varga |
| author_facet | Erika Kajdácsi Zsófia Jandrasics Nóra Veszeli Veronika Makó Anna Koncz Dominik Gulyás Kinga Viktória Köhalmi Kinga Viktória Köhalmi György Temesszentandrási László Cervenak Péter Gál József Dobó Steven de Maat Coen Maas Henriette Farkas Henriette Farkas Lilian Varga Lilian Varga |
| author_sort | Erika Kajdácsi |
| collection | DOAJ |
| description | C1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. Parallel determination of C1-INH-containing activation complexes could be important to understand the regulatory role of C1-INH in diseases such as hereditary angioedema (HAE) due to C1-INH deficiency (C1-INH-HAE). We developed in-house ELISAs to measure the concentration of complexes of C1-INH formed with active proteases: C1r, C1s, MASP-1, MASP-2, plasma kallikrein, factor XIIa, factor XIa, and thrombin, as well as to determine total and functionally active C1-INH. We measured the concentration of the complexes in EDTA plasma from 6 healthy controls, from 5 with type I and 5 with type II C1-INH-HAE patients during symptom-free periods and from five patients during HAE attacks. We also assessed the concentration of these complexes in blood samples taken from one C1-INH-HAE patient during the kinetic follow-up of a HAE attack. The overall pattern of complexed C1-INH was similar in controls and C1-INH-HAE patients. C1-INH formed the highest concentration complexes with C1r and C1s. We observed higher plasma kallikrein/C1-INH complex concentration in both type I and type II C1-INH-HAE, and higher concentration of MASP-1/C1-INH, and MASP-2/C1-INH complexes in type II C1-INH-HAE patients compared to healthy controls and type I patients. Interestingly, none of the C1-INH complex concentrations changed significantly during HAE attacks. During the kinetic follow-up of an HAE attack, the concentration of plasma kallikrein/C1-INH complex was elevated at the onset of the attack. In parallel, C1r, FXIIa and FXIa complexes of C1-INH also tended to be elevated, and the changes in the concentrations of the complexes followed rather rapid kinetics. Our results suggest that the complement classical pathway plays a critical role in the metabolism of C1-INH, however, in C1-INH-HAE, contact system activation is the most significant in this respect. Due to the fast changes in the concentration of complexes, high resolution kinetic follow-up studies are needed to clarify the precise molecular background of C1-INH-HAE pathogenesis. |
| first_indexed | 2024-12-11T14:38:28Z |
| format | Article |
| id | doaj.art-140fbf1dec504fa4a581a64c5e3f3b4e |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-12-11T14:38:28Z |
| publishDate | 2020-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-140fbf1dec504fa4a581a64c5e3f3b4e2022-12-22T01:02:03ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-05-011110.3389/fimmu.2020.00794520993Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema PatientsErika Kajdácsi0Zsófia Jandrasics1Nóra Veszeli2Veronika Makó3Anna Koncz4Dominik Gulyás5Kinga Viktória Köhalmi6Kinga Viktória Köhalmi7György Temesszentandrási8László Cervenak9Péter Gál10József Dobó11Steven de Maat12Coen Maas13Henriette Farkas14Henriette Farkas15Lilian Varga16Lilian Varga17Research Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryMTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, HungaryMTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, HungaryResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryHungarian Angioedema Reference Center, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, HungaryInstitute of Enzymology, Research Centre for Natural Sciences, Budapest, HungaryDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, NetherlandsDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, NetherlandsResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryHungarian Angioedema Reference Center, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryResearch Laboratory, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryHungarian Angioedema Reference Center, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryC1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. Parallel determination of C1-INH-containing activation complexes could be important to understand the regulatory role of C1-INH in diseases such as hereditary angioedema (HAE) due to C1-INH deficiency (C1-INH-HAE). We developed in-house ELISAs to measure the concentration of complexes of C1-INH formed with active proteases: C1r, C1s, MASP-1, MASP-2, plasma kallikrein, factor XIIa, factor XIa, and thrombin, as well as to determine total and functionally active C1-INH. We measured the concentration of the complexes in EDTA plasma from 6 healthy controls, from 5 with type I and 5 with type II C1-INH-HAE patients during symptom-free periods and from five patients during HAE attacks. We also assessed the concentration of these complexes in blood samples taken from one C1-INH-HAE patient during the kinetic follow-up of a HAE attack. The overall pattern of complexed C1-INH was similar in controls and C1-INH-HAE patients. C1-INH formed the highest concentration complexes with C1r and C1s. We observed higher plasma kallikrein/C1-INH complex concentration in both type I and type II C1-INH-HAE, and higher concentration of MASP-1/C1-INH, and MASP-2/C1-INH complexes in type II C1-INH-HAE patients compared to healthy controls and type I patients. Interestingly, none of the C1-INH complex concentrations changed significantly during HAE attacks. During the kinetic follow-up of an HAE attack, the concentration of plasma kallikrein/C1-INH complex was elevated at the onset of the attack. In parallel, C1r, FXIIa and FXIa complexes of C1-INH also tended to be elevated, and the changes in the concentrations of the complexes followed rather rapid kinetics. Our results suggest that the complement classical pathway plays a critical role in the metabolism of C1-INH, however, in C1-INH-HAE, contact system activation is the most significant in this respect. Due to the fast changes in the concentration of complexes, high resolution kinetic follow-up studies are needed to clarify the precise molecular background of C1-INH-HAE pathogenesis.https://www.frontiersin.org/article/10.3389/fimmu.2020.00794/fullC1-inhibitorserine proteasekinetic follow-upactivationhereditary angioedemaHAE attack |
| spellingShingle | Erika Kajdácsi Zsófia Jandrasics Nóra Veszeli Veronika Makó Anna Koncz Dominik Gulyás Kinga Viktória Köhalmi Kinga Viktória Köhalmi György Temesszentandrási László Cervenak Péter Gál József Dobó Steven de Maat Coen Maas Henriette Farkas Henriette Farkas Lilian Varga Lilian Varga Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients Frontiers in Immunology C1-inhibitor serine protease kinetic follow-up activation hereditary angioedema HAE attack |
| title | Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients |
| title_full | Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients |
| title_fullStr | Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients |
| title_full_unstemmed | Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients |
| title_short | Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients |
| title_sort | patterns of c1 inhibitor plasma serine protease complexes in healthy humans and in hereditary angioedema patients |
| topic | C1-inhibitor serine protease kinetic follow-up activation hereditary angioedema HAE attack |
| url | https://www.frontiersin.org/article/10.3389/fimmu.2020.00794/full |
| work_keys_str_mv | AT erikakajdacsi patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT zsofiajandrasics patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT noraveszeli patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT veronikamako patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT annakoncz patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT dominikgulyas patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT kingaviktoriakohalmi patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT kingaviktoriakohalmi patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT gyorgytemesszentandrasi patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT laszlocervenak patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT petergal patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT jozsefdobo patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT stevendemaat patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT coenmaas patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT henriettefarkas patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT henriettefarkas patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT lilianvarga patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients AT lilianvarga patternsofc1inhibitorplasmaserineproteasecomplexesinhealthyhumansandinhereditaryangioedemapatients |